GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Theralase Technologies TLT.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.19

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Theralase Technologies — daily TSXV:TLT Delayed
Market value
C$45.6m
Last close × shares
Volume
29.4k
Shares, 9 Nov 2026

About Theralase Technologies

Its shares trade on TSX Venture under the ticker TLT.V. It has been listed since 2 November 2004. In the fiscal year to 31 December 2025, it reported revenue of C$816,468 and a net loss of C$4.1m. At that date it held total assets of C$3.5m and shareholders' equity of C$1.8m.

Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. The company is headquartered in East York, Ontario. The company went IPO on 2004-11-02. The firm operates through two divisions: Therapeutic Laser Technology (TLT) division and Photo Dynamic Therapy (PDT) division. The TLT division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology is used for healing a range of nerve, muscle and joint conditions, including arthritis, osteoarthritis and wounds. The PDT division develops PDCs and activates them with laser technology to destroy specifically targeted cancers and bacteria. Its TLC-2000 Biofeedback Therapeutic Laser Technology possesses Cell Sensing technology that senses and targets injured tissue. The company is also developing TLC-1000 therapeutic medical laser system. The company is developing TLC-3000 medical laser system for the treatment of a range of cancers.

Figures and description from our data supplier, not checked against the company's own report.

More about Theralase Technologies →

Latest on Theralase Technologies

Our reporting

We have not reported on Theralase Technologies yet.

Next results

10 Nov 2026

Due on 10 Nov 2026. Analysts expect earnings of -0.00 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Theralase Technologies's ticker?

Theralase Technologies trades as TLT.V on TSX Venture, under ISIN CA88337V1004.

What was Theralase Technologies's last closing price?

0.19 on 9 Nov 2026. The figure is in CAD and is never converted.

When does Theralase Technologies next report results?

Results are expected on 10 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.